Benzinga | Aug 25, 2021 07:03AM EDT

Wells Fargo Maintains Overweight on Medtronic, Raises Price Target to $151

Wells Fargo analyst Larry Biegelsen maintains Medtronic (NYSE:MDT) with a Overweight and raises the price target from $140 to $151.